Bicycle Therapeutics plc American Depositary Shares
Market Cap
300M
Short interest (May 15)
3.9%
Net Short (Jun 03 ): -0.1%
Borrow Fee
0.27%
↓ 25.2%
Available Shares
2M
↓ 5.9%
Price Chart
Company Overview
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.